[1]刘宇,朱翠玲.益心解毒法结合磷酸肌酸钠治疗病毒性心肌炎 35例[J].陕西中医药大学学报,2020,(01):080-83.[doi:10.13424/j.cnki.jsctcm.2020.01.020]
 Liu Yu,Zhu Cuiling.35 Cases of the Treatment of Viral Myocarditis by Heart Invigorating and Toxicity Removing Method Combined with Creatine Phosphate Sodium[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):080-83.[doi:10.13424/j.cnki.jsctcm.2020.01.020]
点击复制

益心解毒法结合磷酸肌酸钠治疗病毒性心肌炎 35例()
分享到:

《陕西中医药大学学报》[ISSN: 2096-1340/CN: 61-1501/R]

卷:
期数:
2020年01期
页码:
080-83
栏目:
出版日期:
2020-01-30

文章信息/Info

Title:
35 Cases of the Treatment of Viral Myocarditis by Heart Invigorating and Toxicity Removing Method Combined with Creatine Phosphate Sodium
文章编号:
2096-1340(2020)01-0080-04
作者:
刘宇朱翠玲
1.许昌市中医院,河南 许昌 461000;2.河南中医药大学第一附属医院,河南 郑州 450000
Author(s):
Liu Yu 1 Zhu Cuiling 2
1. The First Internal Medicine Department of Xuchang TCM Hospital, Xuchang China, 461000, 2. Department of Heart Disease of the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou China, 450000
关键词:
益心解毒法磷酸肌酸钠病毒性心肌炎临床疗效
Keywords:
heart invigorating and toxicity removing method creatine phosphate sodium viral myocarditisclinical effect
分类号:
R256.2 R542.2+1
DOI:
10.13424/j.cnki.jsctcm.2020.01.020
文献标志码:
A
摘要:
目的 探讨益心解毒法结合磷酸肌酸钠治疗病毒性心肌炎的临床疗效。方法 选取我院 2016年 2月~2017年 2月间门诊及住院治疗的病毒性心肌炎患者 70例作为研究对象。根据临床不同的治疗方法将 70例患者分为对照组和治疗组,各 35例。对照组患者采用磷酸肌酸钠及常规抗病毒法进行治疗,治疗组患者在对照组基础上给予益心解毒法进行治疗。2个疗程后对比两组患者的临床疗效。结果 两组患者治疗后 LDH、CK及CK-MB均有明显改善(P<0.05),治疗组治疗后 CK及 CK-MB改善情况明显优于对照组(P<0.05)。治疗组总有效 33例、总有效率率为 94.29%,对照组总有效 28例、总有效率为 80.00%,治疗组总有效率均明显高于对照组,两组比较结果差异有统计学意义(P<0.05)。结论 应用益心解毒法联合磷酸肌酸钠治疗病毒性心肌炎患者的临床疗效满意,值得临床进一步推广应用。
Abstract:
Objective to explore the clinical effect of heart invigorating and toxicity removing method combined with creatine phosphate sodium in the treatment of viral myocarditis. Methods Seventy patients with viral myocarditis in our hospital from February 2016 to February 2017 were selected as the research subjects. According to different clinical treatment methods, 70 patients were divided into control group and treatment group, each with 35 cases. Patients in the control group were treated with creatine phosphate sodium and conventional antiviral methods. Patients in the treatment group were treated with heart invigorating and toxicity removing method besides those in the control group. The clinical effects of the two groups were compared after 2 courses. Results After treatment, LDH, CK and CK - MB were significantly improved in the two groups ( P < 0. 05) , and the improvement of CK and CK - MB in the treatment group was significantly better than that in the control group ( P < 0. 05) . The total effective rate of 33 cases in the treatment group was 94. 29%, and the total effective rate of 28 cases in the control group was 80. 00%. The total effective rate of the treatment group wassignificantly higher than that of the control group. ( P <0. 05) . Conclusion The clinical effect of heart invigorating and toxicity removing method combined with creatine phosphate sodium in the treatment of viral myocarditis is satisfactory, and it is worthy of further clinical application.

参考文献/References:

[1]刘迎宣,王雅楠,方庆梅,等.利巴韦林联合黄芪颗粒预防婴幼儿柯萨奇病毒急性发热感染时合并急性病毒性心肌炎的探讨[J].陕西医学杂志,2016,45(4):497-498.
[2]赵妍,王文尧,田间,等.合并低三碘甲状腺原氨酸综合征对急性病毒性心肌炎患者不良心血管事件的影响[J].中华心血管病杂志,2019,47(6):447-451.
[3] Pollack A, Kontorovich A R, Fuster V, et al. Viral myocarditis[ mdash] diagnosis, treatment options, and current controversies[ J] . Nature Reviews Cardiology, 2015, 12( 11) :670.
[4]梁金勇.中西医结合治疗病毒性心肌炎的疗效观察[J].中西医结合心血管病电子杂志,2015,3(6):38-39.
[5]中华医学会儿科学分会心血管学组,中华儿科杂志编辑委员会.病毒性心肌炎诊断标准(修订草案)[J].中国实用儿科杂志,2000,15(5):315.
[6]行海舰.葛根素联合左卡尼汀治疗小儿病毒性心肌炎的临床疗效分析[J].陕西中医,2015,36(10):1297-1298.
[7] Huber S A. Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis. [ J] . Current Pharmaceutical Design, 2016, 22( 4) :408 -426.
[8]赵宗磊,杜松,沈淑馨,等.病毒性心肌炎患者血浆外泌体生物标志物蛋白质组学筛选[J].中华医学杂志,2019,99(5):343-348.
[9]赵述强,李翔宇.病毒性心肌炎中西医防治的研究进展[J].中西医结合心脑血管病杂志,2016,14(18):2115-2118.
[10]林丛,王毅.急性重症病毒性心肌炎 38例临床分析[J].浙江医学,2015,37(21):1783-1784.
[11]王艳玲,李康康,张曾?.急性病毒性心肌炎的中医药研究概况[J].中西医结合心脑血管病杂志,2016,14(18):2118-2121.
[12]王燕,李文芳.小儿病毒性心肌炎辨证施护的临床观察[J].河北中医,2017,39(12):1892-1894.
[13]杨颖,姚凤祯,于亚娟,等.病毒性心肌炎的中医药治疗研究进展[J].中医药学报,2014,42(4):126-127.
[14]陶佳.小儿病毒性心肌炎应用黄芪注射液辅助治疗的效果评 价 [J].中 国 实 用 医 药,2015,10(34):160-161.
[15]郭龙,薛紫鲸,张丹,等.丹参酮类成分治疗心脑血管疾病药理活性研究进展[J].亚太传统医药,2019,15(2):190-192.

相似文献/References:

[1]刘宇朱翠玲.益心解毒法结合磷酸肌酸钠对病毒性心肌炎的疗效分析[J].陕西中医药大学学报,2020,(02):084.[doi:10.13424/j.cnki.jsctcm.2020.02.021]

备注/Memo

备注/Memo:
基金项目:河南省中医药研究专项课题(2016ZY0741)
更新日期/Last Update: 2020-01-15